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Materials and Methods

PEDOT:heparin synthesis
PEDOT:heparin was electrosynthesized on conducting films of PEDOT:PSS on polyethyleneterephthalate substrates (Agfa-Gevaert Orgacon™ F-350) using a three electrode setup, in a polymerization solution of 3,4-ethylenedioxythiophene (EDOT) (Sigma) and Klexane (Sanofi Aventis). A platina grid was used as counter electrode and Ag/AgCl as reference electrode, controlled by an Ecochemie µAutolabIII (Metrohm Autolab, Utrecht, NL) potentiostat. A solution of 3 ml of 10 mg ml -1 Klexane (Sanofi Aventis), 27 ml H 2 O, and 300 µl 3,4-ethylenedioxythiophene (EDOT) (Sigma) was stirred overnight. Electrosynthesis was carried out for 1200s at 400 µA. The size of the PEDOT:PSS substrate was about 6 cm 2 . Polymerization at approximately 65 µA/cm 2 for 1200 s resulted in a film thickness of about 400 nm.
PEDOT:heparin characterization
The thickness of the synthesized PEDOT:heparin films was measured with a Dektak 3ST surface profiler (Veeco Instruments, Plainview, NY, USA). The surface energy of PEDOT:heparin was evaluated by measuring and analyzing the water contact angles with a goniometer (Cam 200, KSV Instruments, Helsinki, Finland) and accompanying software. Electrochemical characterization of PEDOT:heparin surfaces was done using cyclic voltammetry at 20 mV/s in a setup as described above with 0.1M NaCl as electrolyte. Atomic force microscopy of PEDOT:heparin was done with a Dimension 3100 instrument from Veeco in tapping mode using a 10 µm scan size. The X-ray photoelectron spectroscopy (XPS) experiments were carried out using a Scienta ESCA 200 spectrometer. The vacuum system consisted of an analysis chamber and a preparation chamber. XPS was performed in the analysis chamber at base pressure of 10 -10 mbar, using monochromatized Al Kα X-rays, at hν = 1486.6 eV. The experimental conditions were such that the full width at half maximum (fwhm) of the gold Au(4f7/2) line was 0.65 eV. The binding energies were obtained with an error of ± 0.05 eV. XPS measurements were carried out on pristine, oxidized (0.8 V 5 min) and reduced (-0.8V 5 min) PEDOT:heparin films. The oxidized and reduced films were blow-dried using He-gas prior to insertion into the vacuum system.
Toluidine blue assay
Briefly, PEDOT:heparin surfaces were reduced to the neutral state or oxidized (first reduced and then switched to oxidized by ramping 0.1 V/s) in an electrochemical setup as above followed by incubation in 2 ml TB solution for 2 hours. The TB solution was composed of 0.05 mg ml -1 TB (Sigma) in 0.01 M HCl and 0.2% w/v NaCl. After incubation, the solution was diluted 1:10 in ethanol (99.5%) and absorption was measured between 500 and 800 nm, with an absorption maximum at 631 nm. Absorption was measured with an UV-VIS-NIR spectrometer Lambda 900 from Perkin Elmer. For incubated polymer samples, shaking against n-hexane was omitted as the TB:Klexane complex formed during the assay would be present on the polymer surface, not in solution. Therefore, there was no need to remove the complex.
Cell culture and surface preparations
For growth factor (GF) association and cell culture studies PEDOT:heparin surfaces were sterilized by immersion in ethanol (70%) for 15 min followed by air drying. Surfaces were then immersed for 48 h in PBS. For association of GFs to PEDOT:heparin surfaces, the surfaces were reduced (-0.8 V 5min) to the neutral state in PBS using a three electrode setup as above. Thereafter, the surfaces were immersed in 200 ng ml -1 basic fibroblast growth factor, bFGF (denoted as FGF2 in this work), (RnD Systems) in 2 mg ml -1 BSA in PBS for 1h at 37 degrees, followed by 2 times of rinsing in PBS. Prior to cell seeding the surfaces were coated with 15 µg ml -1 poly-ornithine (SigmaAldrich) followed by 1 µg ml -1 fibronectin. To evaluate the decrease of surface exposed FGF2, surfaces were cycled 3 times at -0.8 to 0.8 V, 0.1 V/s followed by a constant oxidizing potential 0.8 V for 5 min in cell culture media described below.
Primary neural stem cells (NSCs) were obtained from cerebral cortices of Sprague-Dawley rat embryos at embryonic day 15.5. Animals were treated according to institutional and national guidelines (Ethical permit no. N79/08). NSCs were expanded on poly-ornithine and fibronectin coated tissue culture polystyrene in serum-free DMEM:F12 medium with N2 supplement [12a] . 10 ng ml -1 FGF2 was added daily to maintain the proliferative NSC state. Passaging of NSCs was done by dissociation in HBSS, HEPES and NaHCO 3 . In all experiments, cells at passage two (P2) were used.
Cells were seeded at ~16000 cells/cm 2 and cultured for 4 days. For samples with FGF2 in solution, the GF was added daily. Experiments in which oxidation was done during cell culture were performed after overnight culturing, with cycling of the potential during oxidation being omitted. Instead, a potential was swept from -0.8 to 0.8 V at 0.05 V/s. Reference surfaces were kept at open circuit.
Immunoreactivity of PEDOT:heparin/GF, and cell assays
To quantify the amount of antibody accessible growth factors, FGF2 and FGF8 (RnD systems), surfaces were treated as above with the exception that FGF8 was incubated at 500 ng ml -1 . The surfaces were then fixated in 10 % formalin for 15 min at RT. Blocking was done in 100 mg ml -1 BSA in PBS/0.1% Triton-X (PBST) for 20 min in RT, followed by two times rinsing in PBST. Primary antibodies 5 µg ml -1 goat anti-FGF basic (RnD Systems) or 5 µg ml -1 goat anti-FGF 8b (RnD Systems) and 1.2 µg ml -1 rabbit anti-fibronectin (Sigma) were incubated overnight in10 mg ml -1 BSA PBST. Next, rinsing in PBST was done six times for 5 min. Species specific secondary antibodies conjugated with Alexa-488 or Alexa-594 at 4 µg ml -1 in 10 mg ml -1 BSA PBST were incubated in darkness at RT for 1h. Rinsing in PBST, followed by PBS was done prior to evaluation in fluorescence Zeiss Axioskop2 microscope and a Zeiss AxioCam MRm camera with Axiovision Rel 4.6 software.
Fixation of NSCs was done in 10 % Formalin for 15 min. Permeabilization was done through three times 5 min incubation in PBST. Primary and secondary antibody incubations were done as described above, without a blocking step. The following primary antibodies were used: mouse anti-Nestin from BD Biosciences Pharmingen (1:500) and rabbit anti-glial fibrillary acidic protein (GFAP) from Dako (1:500). Cell nuclei were counterstained with 4ʹ′,6-diamidino-2-phenylindole (DAPI) from Invitrogen.
Quantitative real-time PCR (RT-QPCR) was performed after 4 days of culturing. RNA was extracted using RNeasy microkit including RNase free DNase kit (Qiagen). cDNA was synthesized from 200 ng of RNA using High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Real-time PCR was carried out using Platinum SYBR Green qPCR SuperMix UDG (Invitrogen) and the 7300 Real Time PCR System using the following thermo cycling program: 50°C for 2 min, 95°C for 2 min and 40 cycles of 95°C for 15 s and 60°C for 30 s, and finally 95°C for 15 s, 60°C for 1 min and 95°C for 15 s. Each sample was run in triplicates. The ∆∆C T method was used to evaluate mRNA levels relative to TATA binding protein (TBP), which was the endogenous control. Primers are available upon request.
Quantification of surface bound FGF2
For quantification of surface bound FGF2, [ 125 -I]FGF2 (PerkinElmer and a gamma counter (LKB Wallac Compugamma) was used. Exact area of each surface was determined with a phosphoimager.
Statistical analysis
All statistical analysis was done in Graphpad Prim 5 using one-way ANOVA with post analysis Tukey test, alternatively a two-tailed t-test was used. Significance level was set to 0.05, ** = p<0.01, *** = p< 0.001. The S(2p) core level was fitted with two spin split doublets corresponding to sulfur atoms in PEDOT (low binding energy) and in heparin (high binding energy), respectively. Dots mark the raw data that have been fitted with spin-split doublets and a Shirley background. a) For the pristine film, the PEDOT-to-heparin sulfur ratio was ~3.5. b) For the neutral sample, the PEDOT-to-heparin sulfur ratio was significantly increased to ~7.1. This loss of heparin on the film surface is due to a decrease in the amount of positive charge of PEDOT upon reduction, resulting in weaker electrostatic interactions between the heparin molecules and PEDOT. The heparin molecules on the surface of the films can then be removed by blow-drying the samples with a stream of helium. c) Upon electrochemical oxidation of neutral PEDOT and blowdrying with helium gas, the PEDOT-to-heparin sulfur ratio was ~4.4. The relative increase in surface heparin in oxidized PEDOT compared to the neutral films is consistent with the presence of tighter interactions between heparin and PEDOT in oxidized films. 
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